Reinforced follow-up for children and adolescents with type 1 diabetes and inadequate glycaemic control: A randomized controlled trial intervention via the local pharmacist and telecare

Diabetes and Metabolism

Volumn 32, Issue 2, 2006, Pages 159-165

  Gay, C L ^a,b   Chapuis, F ^b   Bendelac, N ^a   Tixier, F ^a   Treppoz, S ^a   Nicolino, M ^a  

^a HÔPITAL DEBROUSSE   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Adolescents children; Glycaemic control; Pharmacist; Telecare; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FAMILY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PATIENT COMPLIANCE; PHARMACIST; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; STATISTICAL SIGNIFICANCE; TELECARE;

EID: 33645963778     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70263-X     Document Type: Article

References (26)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
2. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial. J Pediatr 1994;125:177-88
3. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9
4. Dorchy H, Roggemans MP, Willems D. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience. Diabetes Care 1997;20:2-6
5. American Diabetes Association. Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care 2002;25:S33-S49
6. Kaufman FR, Halvorson M, Carpenter S. Association between diabetes control and visits to a multidisciplinary pediatric diabetes clinic. Pediatrics 1999;103:948-51
7. Jacobson AM, Hauser ST, Willett J, Wolfsdorf JI, Herman L. Consequences of irregular versus continuous medical follow-up in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997;131:727-33
8. Couper JJ, Taylor J, Fotheringham MJ, Sawyer M. Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes. Diabetes Care 1999;22:1933-7
9. Conseil de l'ordre des pharmaciens. Available from http://www.ordre.pharmacien.fr/fr/jaune/index3.htm, accessed 20 august 2004
10. Keely JL, American College of Physicians-American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med 2002;136:79-85
11. Fermon C. Today data management in self-monitor ing of blood glucose for diabetic patients. Diabetes Metab 2003;29:S31-6
12. Montori VM, Helgemoe PK, Guyatt GH, et al. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care 2004;27:1088-94
13. Biermann E, Dietrich W, Rihl J, Standl E. Are there time and cost savings by using telemanagement for patients on intensified insulin therapy? A randomised, controlled trial. Comput Methods Programs Biomed 2002;69:137-46
14. Ahring KK, Ahring JP, Joyce C, Farid NR. Telephone modem access improves diabetes control in those with insulin-requiring diabetes. Diabetes Care 1992;15:971-5
15. Klonoff DC. Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical? Diabetes Care 2003;26:1626-8
16. Gomez EJ, Hernando ME, Garcia A, et al. Telemedicine as a tool for intensive management of diabetes: the DIABTel experience. Comput Methods Programs Biomed 2002;69:163-77
17. Liesenfeld B, Renner R, Neese M, Hepp KD. Telemedical care reduces hypoglycemias and improves glycemic control in children and adolescents with type 1 diabetes. Diabetes Technol Ther 2000;2:561-7
18. Marrero DG, Vandagriff JL, Kronz K, et al. Using telecommunication technology to manage children with diabetes: the Computer-Linked Outpatient Clinic (CLOC) Study. Diabetes Educ 1995;21:313-9
19. Chase HP, Pearson JA, Wightman C, Roberts MD, Oderberg AD, Garg SK. Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care 2003;26:1475-9
20. International Society for Pediatric and Adolescent Diabetes. ISPAD Consensus Guidelines for the management ot Type 1 diabetes mellitus in children and adolescents. Zeist, Netherlands, PGF Swift Publ Medforum, 2000
21. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002;162:1149-55
22. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002;288:1594-602
23. Campbell RK. Role of the pharmacist in diabetes management. Am J Health Syst Pharm 2002;Suppl 9:S18-21
24. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG Jr. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 2002;22:1294-300
25. ASHP therapeutic position statement on strict glycemic control in selected patients with insulin-dependent diabetes mellitus. Am J Health Syst Pharm 1995;52:2709-11
26. Hirsch IB. The burden of diabetes (care). Diabetes Care 2003;26:1613-4